IPO - ABL Longevity Growth & Income Fund
Form Type: N-2/A
Filing Date: 2025-01-16
Corporate Action: Ipo
Type: Update
Accession Number: 000119312525007216
Filing Summary: ABL Longevity Growth and Income Fund is a newly organized, continuously offered, non-diversified closed-end investment company structured as an interval fund. The Fund intends to operate by offering shares that will be subject to transfer restrictions and quarterly repurchase offers of at least 5% of its outstanding shares at NAV. The Fund plans to invest primarily in longevity assets, focusing mainly on mortality contracts, with an additional investment in annuity contracts and other structured finance products. It aims to provide long-term appreciation and current income. The Fund will engage in a continuous offering of its shares and has the potential for significant risks due to the nature of its investments, which could include premium increases on mortality contracts and the speculative nature of the underlying longevity assets.
Document Link: View Document
Additional details:
Sales Load: up to 5%
Redemption Fee: 1.00% on certain repurchases within 12 months
Management Fee: may be adjusted downward but never upward
Distribution Fee: 0.25% annual rate
Shareholder Servicing Fee: up to 0.15% per year
Minimum Investment Amount: $10,000 initial; $1,000 subsequent
Comments
No comments yet. Be the first to comment!